What is Meclizine Prescription?
Meclizine is available in prescription strength (brand name Antivert®). It is uses in the prevention and treatment of symptoms of motion sickness; management of vertigo with diseases affecting the vestibular system
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Vertigo | 39 |
|
|
4 | |||
| Dizziness | 18 |
|
1 | ||||
| Other | 7 |
|
1 | ||||
| dizziness/ "spinning" | 3 |
|
|
2 | |||
| vertigo & nausea | 2 | 0 | |||||
| Brain fog | 1 | 0 |
See all 60 patients currently taking Meclizine Prescription
Mouse over the table for more information
Side Effects
Dosages
Top 10 dosages based on patients currently taking Meclizine Prescription. See all 18 dosages ►
| 100mg as needed | 10mg as needed | 12.5 mg as needed | 12.5mg as needed | 20 mg as needed | 20mg as needed | 25 mg all the time (24/7) | 25mg as needed | 2mg as needed | 3mg as needed | 75mg as needed | 3 mg daily | 3 other daily | 12.5 mg daily | 25 mg daily | 37.5 mg daily | 50 mg daily | 100 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1
|
1
|
2
|
6
|
1
|
3
|
1
|
22
|
1
|
1
|
1
|
1
|
2
|
3
|
8
|
1
|
3
|
1
|
||
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Course of treatment ended
|
6 | 33% |
|
|
Did not seem to work
|
4 | 22% |
|
|
Other
|
4 | 22% |
|
|
Doctor's advice
|
2 | 11% |
|
|
Expense
|
1 | 6% |
|
See all 17 patients who’ve stopped taking Meclizine Prescription
Adherence, Burden & Cost See details from patient evaluations ▼
Patient Evaluations
See all 7 patient evaluations
-
- gaby
- Sex: F
- Sensation: Moderate
- Overall: Moderate
- Cognition: moderate
- Vision: moderate
- Speech: moderate
- Swallowing: moderate
- Upper limb: moderate
- Walking: moderate
- See profile
-
-
- gaby
- 12.5mg as needed
- since Oct 28, 2008
-
Efficacy
Moderate
for Other
-
Side Effects
Mild
- See full evaluation
See all 7 patient evaluations
Report created on November 21, 2009.